BROOKE CAUSLAND: Open Payments
NPI 1457951303 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,910 in 130 payments from 16 companies in 2025. Trend: 2023 $1,416 · 2024 $2,214 · 2025 $2,910
Food & beverage: $2,876Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $792 |
| GlaxoSmithKline, LLC. | 30 | $439 |
| Regeneron Healthcare Solutions, Inc. | 11 | $251 |
| Grifols USA, LLC | 8 | $229 |
| GENZYME CORPORATION | 11 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $158 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $151 |
| Mallinckrodt Hospital Products Inc. | 5 | $146 |
| Baxter Healthcare | 5 | $106 |
| Amgen Inc. | 4 | $96 |
Products named: DUPIXENT, TEZSPIRE, TRELEGY ELLIPTA, Prolastin-C Liquid, AIRSUPRA, NUCALA, BREZTRI, FASENRA.
Industry payments across AL — which companies pay providers there.
